Šīs tīmekļa vietnes satura kvalitātes uzlabošanai un pielāgošanai lietotāju vajadzībām tiek lietotas sīkdatnes - tai skaitā arī trešo pušu sīkdatnes. Turpinot lietot šo vietni Jūs piekrītat sīkdatņu lietošanai.
Presentation given during the webinar held on March 6, 2013
Emitents Olainfarm, AS (213800WCG52W62ENOP27)
Veids Citi
Valoda EN
Statuss Publicēts
Versija
Datums 2013-03-07 10:02:08
Versijas komentārs
Teksts

Presentation given during the webinar held on March 6, 2013

During the webinar held on March 6, 2013, Member of the Board of AS "OlainFarm" Salvis Lapins gave the enclosed
presentation about the update of company's recent developments.

Among other things the participants were informed, that should the amount of unaudited profit and previously announced
intention of the Board remain unchanged a dividend of 0,1 lats per share could be expected for 2012.


A/s Olainfarm is one of the biggest pharmaceutical companies in Latvia with 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more
than 30 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
    Salvis Lapins
    Member of the Board
    A/s „Olainfarm”
   Tel: +371 6 7013 717
 e-mail: Salvis.Lapins@olainfarm.lv

Pielikumi
webinarmarch13.pdf (1342.74 kB)